NCT02436707 Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02423915 Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention Status COMPLETED Phase PHASE1
NCT02423356 Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin Status COMPLETED Phase N/A
NCT02419469 Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Status TERMINATED Phase PHASE2
NCT02414724 Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma Status TERMINATED Phase PHASE1
NCT02409121 A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers Status COMPLETED Phase NA
NCT02408042 Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) Status WITHDRAWN Phase PHASE1/PHASE2
NCT02392039 Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma Status TERMINATED Phase EARLY_PHASE1
NCT02383368 A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma Status COMPLETED Phase PHASE1
NCT02370446 Testing a Personalize Medication Log for Patients With Lymphoma Status COMPLETED Phase N/A
NCT02369653 A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase Status COMPLETED Phase PHASE3
NCT02356549 African American Cancer Clinical Trial Decisions: Testing Tailored Messages Status COMPLETED Phase NA
NCT02349698 A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma Status UNKNOWN Phase PHASE1/PHASE2
NCT02347878 Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH) Status UNKNOWN Phase PHASE4
NCT02332668 A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) Status RECRUITING Phase PHASE1/PHASE2
NCT02327078 A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) Status COMPLETED Phase PHASE1/PHASE2